title: Influenza virus resistance to oseltamivir: what are the implications?
authors.affiliation: 1 Birmingham Research Unit of the Royal College of General Practitioners, Harborne, Birmingham, UK. dfleming@rcgpbhamresunit.nhs.uk
authors.forename: Douglas M
authors.initials: DM
authors.lastname: Fleming
authors.forename: Alex J
authors.initials: AJ
authors.lastname: Elliot
authors.forename: Adam
authors.initials: A
authors.lastname: Meijer
authors.forename: W John
authors.initials: WJ
authors.lastname: Paget
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D004189:Disaster Planning; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy / Q000453:epidemiology / Q000821:virology*; D053139:Oseltamivir / Q000494:pharmacology*
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir